Xuanzhu Biological -(02575) Included in the Hang Seng Composite Index Constituents

2026-02-22 12:10:20

CITIC Securities Finance APP News, Xuanzhu Biological-B (02575) announced that, according to the Hang Seng Index Company’s quarterly review results for the period ending December 31, 2025, published on February 13, 2026, the company has been included in the Hang Seng Composite Index. This adjustment will take effect on March 9, 2026.

As a comprehensive benchmark index for Hong Kong stocks, the Hang Seng Composite Index covers all listed companies on the Main Board of the Hong Kong Stock Exchange that rank in the top 95% by market capitalization. Being included in the Hang Seng Composite Index is expected to meet the inclusion criteria for trading through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs. These programs are channels for stock trading and investment between investors in Hong Kong and mainland China.

The board of directors believes that the inclusion in the Hang Seng Composite Index reflects investors’ recognition of the company’s value and growth potential. The board anticipates that this inclusion will enhance the company’s stock liquidity, expand its investor base, and diversify its shareholder structure, thereby further improving the company’s reputation and investment value in the capital market, which is beneficial for the company’s long-term stable development.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.